Katherine A. McGlynn

National Cancer Institute, National Institutes of Health

Dr. Katherine McGlynn is currently the Deputy Branch Chief and Senior Investigator in the Division of Cancer Epidemiology & Genetics at the National Cancer Institute. She received an M.P.H. in population studies from Tulane University and a Ph.D. in epidemiology from the University of Pennsylvania. She conducted postdoctoral research on liver cancer at the Fox Chase Cancer Center, where she subsequently served as a faculty member before coming to the NCI in 1998. Dr. McGlynn has been the recipient of an NIH Merit Award for her study of testicular cancer among military servicemen and an NCI Outstanding Mentor Award.

Dr. McGlynn has been using a variety of study designs to investigate environmental and genetic risk factors that may contribute to increasing rates of Cancer. Dr. McGlynn has been studying a number of TDS outcomes in complementary studies.  Her TDS research is currently oriented around several areas of investigation: maternal/son hormonal effects, endocrine-disrupting chemicals, and perinatal factors.  One of her principal interests in TDS is the relationship of steroid hormones and gonadotropins to the development of TDS outcomes. 

Dr. McGlynn has also been studying the relationship of organochlorine compounds to several TDS outcomes. She has identified relationships between TGCT and some pesticides, but has not seen these same relationships with cryptorchidism and hypospadias, suggesting that post-natal, rather than pre-natal, exposure to these compounds may be critical to increasing risk of TGCT.  She is currently broadening her research to include endocrine-disrupting chemicals currently in use, and certain medications.